Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Willhem AB in connection with purchase of 11 100 tenancies
Mandate

Vinge advises Willhem AB in connection with purchase of 11 100 tenancies

December 09, 2010

Vinge has advised Willhem AB in connection with the purchase of 11 100 tenacies in Stockholm, Gothenburg, Malmö, Jönköping, Borås, Karlstad and Linköping with an underlying property value of approximately SEK 7 billion. The transaction comprises a total of 860 000 sq. m.,  87 per cent of which are residential properties. Första AP-fonden (the "First Swedish Pension Fund") is the sole owner of Willhem AB. The sellers are Boligutleie Holding I AS, Hyresfastigheter Holding I AB and Hyresfastigheter Holding III Gul AB, owned by customers of Acta. The transaction is conditional upon approval thereof at general meetings to be held in December and upon approval by the Swedish Competition Authority.

Vinge's team consisted of partner Patrick Forslund together with, among others, associates Anders Frick, Martin Folke and Daniel Unger.

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

 Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

 Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026